Announced Fri, 4 Sept · 11:56 IST
SMS Pharma files FY26 Business Responsibility and Sustainability Report
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+6.3%1-day move
₹374.10
prior close
₹383.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.2-0.1+0.7+6.3+6.5+9.5+11.2+24.6+7.8————
Up moveDown movePending
AI summary
SMS Pharmaceuticals filed its BRSR for FY 2025-26. It manufactures Active Pharmaceutical Ingredients (99% of revenue), with 66% exports to 45 countries. Revenue was about Rs 886.87 crores. The company is ISO 14001 and 45001 certified, has installed 1363 KW rooftop solar, and invested Rs 1.9 crores in effluent treatment. Zero fatalities or safety incidents were reported. Women form 12.5% of the board.
Likely market impact
Routine ESG compliance filing under SEBI rules. No new material action; sustainability metrics show operational improvements but reduced green capex share.